Bird Flu :: Australia’s CSL says bird flu vaccine test a success

Australia’s drug manufacturer CSL Ltd. says bird flu vaccine clinical trials are successful. Bird flu vaccine is the first to be registered in the Southern Hemisphere.

CSL, the world top plasma products maker, said trials just completed showed two 30mg doses of its vaccine delivered three weeks apart produced a strong immune response against the deadly H5N1 avian flu virus in adults aged 18 to 65.

The new vaccine would be registered with Australia’s drug safety watchdog, the Therapeutic Goods Administration (TGA), which had promised to accelerate assessment given the potential threat posed by bird flu.

Leave a Comment